MoD · NATO · UKDI · Defence Procurement — Battlefield Medical Technology

DEFENCE &
PROCUREMENT.

Five devices. One protocol. Any soldier. The doctrinal gap that kills is the gap this fills.

887Preventable deaths — Eastridge 2012
68+Minutes evacuation window
<2minFull protocol execution
£1.2MUKDI ask — TRL 3→7

THE DOCTRINAL
GAP THAT KILLS.

Haemorrhagic shock kills 40% of potentially survivable combat casualties. The Eastridge et al. 2012 analysis of 4,596 combat deaths across Iraq and Afghanistan identified 887 potentially survivable haemorrhage deaths. These soldiers did not die because their wounds were unsurvivable.

They died in the gap. The gap between wounding and the arrival of a medic. The gap between the casualty's own limited interventions and the treatment they needed. Every existing prehospital stabilisation protocol assumes a trained medic is present. In large-scale combat operations against a peer adversary — the operational environment the British Army must now plan for — that assumption fails at scale.

NTL Programme Documentation

"The doctrinal gap is not a shortage of blood products. It is the absence of any intervention that the casualty or an untrained buddy can execute in the first two minutes after wounding — before anyone else arrives."

Current capability
Medic-administered only — no self-care protocol exists
Cold chain for plasma — forward operating logistics infeasible
Haemostatic gauze biologically silent after clotting
Evacuation window fixed at 36 minutes — peer adversary context breaks this
Plasma priming requires clinical skill and sterile equipment
RAPID Family closes
RAPIDPen — self-administered TXA + ketamine in 2 seconds through clothing
RAPIDPlasma — freeze-dried, frangible membrane, no cold chain
RAPIDGauze — haemostasis + MRSA antimicrobial + wound healing from application
Evacuation window extended to 68+ minutes
RAPIDConnect — pre-primed, no skill, remove caps and connect

FIVE DEVICES.
ONE PROTOCOL.

Five point-of-wounding devices executed in sequence in under two minutes by the casualty themselves or an untrained buddy. No medic. No cold chain. No clinical skill required. Every device is a UK patent application.

NTL-001 · 22 Claims

RAPIDPen

Dual-chamber auto-injector

TXA arrests coagulopathy. Sub-anaesthetic ketamine reduces mean arterial pressure 40–45%, cutting ongoing blood loss before volume replacement begins. Self-administered outer thigh through clothing. Two seconds. BinaJect dual-chamber platform (ATNAA precedent).

2 seconds · Outer thigh · Through clothing
NTL-002 · 25 Claims

RAPIDPlasma

Frangible-membrane plasma unit

500ml freeze-dried plasma. Bend to crack the internal frangible membrane. Shake to mix. No separate water. No syringe. No clinical skill. Reconstituted plasma ready in 2 minutes. No cold chain logistics requirement.

2 minutes · No cold chain · No skill
NTL-003 · 22 Claims

RAPIDConnect

Pre-primed sterile transfer line

Factory-filled WFI to BP/EP monograph. Dual male Luer lock — compatible with all standard IO and IV interfaces. Remove caps, connect, open clamp. Eliminates the last point of failure in field plasma delivery. No haemolysis risk.

Dual Luer lock · All standard IO/IV · Pre-primed
GB2606416.2

RAPIDGauze

Holobiont-intact wound packing

TCCC-compatible drop-in replacement for QuikClot. Cold-processed sargassum — holobiont intact, native sulphation preserved. Haemostasis. Then MRSA-active antimicrobial. Then NF-κB anti-inflammatory activity. Then wound healing initiation. Simultaneously. From application.

TCCC drop-in · MRSA-active · Biologically active after haemostasis
NTL-004 · 22 Claims

SENTINEL

Battlefield biosensor mesh

Autonomous mesh-networked vital signs monitoring. Distributed sensor array — TCCC-capable, pre-evacuation triage support. Unit-level medical picture without a medic present. Companion system to the RAPID Family — once the protocol is executed, SENTINEL monitors while evacuation is coordinated.

Mesh network · Autonomous broadcast · Pre-evacuation triage
BUILT · OPERATIONAL

VANTAGE

Voice-first execution layer — military configuration

Browser-based. Any device with a camera and microphone. No app to certify. Token-gated military access — completely isolated from civilian product. 19 languages auto-detected. Operator role: terse, military reporting formats (SALUTE, CONTACT, SITREP). Medic role: nine-line MEDEVAC output. Up to 10,000 device tokens per batch. Surgical revocation at device or unit level via single API call.

No app certification · Token-gated · 19 languages · Live demo available

SDICS.
SAFE DONOR ID.

The Soldier Donor Identification and Compatibility System. Walking blood bank enablement in peer adversary mass-casualty environments. Cold chain fails at scale — SDICS enables safe buddy-to-buddy blood donation with zero clinician involvement.

Blood type verification. Donor eligibility screening. Crossmatch risk mitigation. Transfusion event logging. Unit-level compatibility data accessible to the medic who eventually arrives — not just at the point of care but as a documented record for forward medical facilities.

Blood type verificationZero clinician
Donor eligibilityAutomated screening
Event loggingForward medical record
Clinical teamProf Steven Jeffery (NDA signed)

ASCENT.
MEDICAL AUTHORITY CONTINUITY.

ASCENT is the protocol that answers a question the MoD has not formally resolved in doctrine: what happens to medical authority when the medic is the casualty, in a peer adversary contact, where radio silence is non-negotiable and the patrol cannot stop fighting.

Four systems — SENTINEL, SDICS, VANTAGE, HEARTBEAT — integrated into a single competency-aware, noise-disciplined medical authority continuity protocol powered by SUCCESS.ION (GB2607848.5, filed 5 April 2026). The patrol never has zero medical authority. The system degrades gracefully through defined failover states, each one logged, each one reported to Line 2 at the earliest safe opportunity. No radio call. No audio alert. No pause in the fight.

ASCENT — Full protocol →
State 1 — NominalMedic operational · WBB pre-identified
State 2 — Man DownMedic notified · MIST initiated · WBB ready
State 3 — WBB ActiveMedic discretion · Visual only · No audio
ASCENT — AutoCompetency-aware silent promotion
ASCENT — FinalManual self-designation · Biometric · Logged · Line 2

PROCUREMENT
TIMELINE.

UK Defence and Security Accelerator (UKDI) submission window now open. Innovation Outline due 19 May 2026. Full submission 2 June 2026. £750K–£1.2M. TRL 3→7 over 18 months.

19 MAY 2026 — Deadline

UKDI Innovation Outline

Innovation Outline submission. High-level capability description, problem statement, proposed solution approach, team credentials, and initial TRL assessment. NDA-protected technical detail available to qualified UKDI contacts on request.

2 JUN 2026 — Deadline

UKDI Full Submission

Full submission. Complete technical package, clinical data, IP schedule, development roadmap, team structure, cost breakdown. £750K–£1.2M ask. TRL 3→7 target over 18 months. Clinical co-investigator: Prof Steven Jeffery (NDA signed).

Q3 2026 — Target

Pre-Clinical Validation Programme

Porcine haemorrhagic shock model validation of full RAPID protocol. Ex vivo tissue testing of RAPIDGauze holobiont compound profile. SDICS compatibility algorithm validation. Target: complete preclinical dataset for Phase I regulatory pathway.

Q1 2027 — Target

Phase I Clinical Programme

Phase I safety and tolerability for RAPIDPen (TXA + ketamine dosing). Human factors validation for RAPIDPlasma frangible-membrane activation in field conditions. Regulatory submission pathway through MHRA/EMA for CE marking. Battlefield medicine regulatory fast-track applicable.

18 MO Programme target

TRL 7 — System Prototype Demonstration

Full system prototype demonstration in operationally representative environment. RAPID protocol validated by non-clinical operators. SENTINEL mesh demonstrated at squad level. SDICS walking blood bank scenario exercised. Procurement recommendation package delivered to MoD/UKDI.

PROGRAMME
OVERVIEW.

ParameterDetail
ProgrammeUK Defence Innovation (UKDI) — Battlefield Medical Technology
Innovation Outline19 May 2026
Full Submission2 June 2026
Ask£750,000 – £1,200,000
TRL at submissionTRL 3 (proof of concept demonstrated)
TRL targetTRL 7 (system prototype demonstrated in operational environment)
Programme duration18 months
Clinical leadProf Steven Jeffery — NDA signed
IP statusNTL-001/002/003/004 · GB2606416.2 — UK patent applications filed March 2026
Regulatory pathwayMHRA Class III (RAPIDPen) · CE marking · Battlefield medicine fast-track applicable
ASCENT ProtocolMedical Authority Continuity Protocol. Powered by SUCCESS.ION (GB2607848.5, filed 5 April 2026). Integrates SENTINEL, SDICS, VANTAGE, HEARTBEAT. Competency-aware automatic failover when medic is casualty. Rank-gated qualification hierarchy. Silent promotion — visual only, no audio in contact. Biometric-authenticated self-designation with tiered confirmation gateway for occupied roles. Coercion detection via VANTAGE multimodal baseline monitoring. Unbroken chain of medical authority under any casualty scenario. Full protocol →
VANTAGE MilitaryBrowser-based voice execution layer. Token-gated. Operator (SALUTE/CONTACT/SITREP) and Medic (nine-line MEDEVAC) roles. 19 languages auto-detected. Batch token provisioning to MDM. Built and operational. No app certification required. Full specification →
NATO applicabilitySTANAG 2939 TCCC alignment · Drop-in replacement for existing haemostatic gauze
NDAFull technical package available under NDA to qualified procurement contacts

Procurement Contact — NDA Available

NDA-PROTECTED
TECHNICAL DETAIL
ON REQUEST.

Full mechanism data, preclinical package, device engineering specifications, IP schedule, regulatory pathway assessment, clinical team credentials, and UKDI submission documentation are available to qualified MoD, UKDI, NATO, and prime contractor procurement contacts under NDA. Contact directly — no gatekeeping, no account management, no intermediary.

Kirk Harper — Founder, NeuroSync Technologies Limited

kirk_harper@neurosync-technologies.ltd

+44 7944 299117

Scroll to Top